# US 2025/0082825 A1 · Threads of cross-linked hyaluronic acid and hydroxyapatite

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082825 A1
- Document ID: US20250082825A1
- Status: Published application
- Kind: A1
- Application number: 18/772,596
- Filed: 2024-07-15
- Published: 2025-03-13
- Earliest claimed: 2016-07-27
- Assignees: Marbelle Threads Ltd.
- Applicants: Marbelle Threads Ltd.
- Inventors: David Dadi SEGAL; Eran Goldberg; Lital Shklanovsky; Aviv Cohen; Liat Goldshaid-Zmiri
- Web page: https://patentgrep.com/patent/US20250082825A1

## CPC

- A61L 27/46: with phosphorus-containing inorganic fillers
- A61L 27/12: Phosphorus-containing materials, e.g. apatite
- A61L 27/20: Polysaccharides
- A61L 27/44: having a macromolecular matrix
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- C08J 3/24: Crosslinking, e.g. vulcanising, of macromolecules (mechanical aspects B29C35/00; crosslinking agents C08K)
- C08J 2305/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- C08L 5/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

Disclosed herein are threads of cross-linked hyaluronic acid and hydroxyapatite, the precursor compositions from which they are prepared and processes for their manufacturing.

## Claims

### Claim at position 1

1-22. (canceled).

### Claim 23

A process of manufacturing a thread of hyaluronic acid and calcium hydroxyapatite comprising:
cross-linking in an aqueous medium hyaluronic acid or a salt thereof by adding a cross-linking agent and increasing the pH of the medium;
neutralizing said aqueous medium;
wherein calcium hydroxyapatite is present in said aqueous medium before said neutralizing, providing an extrudable thread precursor composition;
forming said precursor composition into a wet thread; and
drying said wet thread to furnish a dry thread.

### Claim 24 (depends on 23)

The process of claim 23, comprising adding a base to a reaction vessel which was previously charged with hyaluronic acid and a cross-linking agent, to form an alkaline reaction mixture, allowing the reaction mixture to commence cross-linking, adding and dispersing calcium hydroxyapatite into said reaction vessel, allowing said reaction mixture in said reaction vessel to complete cross-linking reaction, and neutralizing said aqueous medium by adding a buffering agent to bring the pH value to an essentially neutral value.

### Claim 25 (depends on 23)

The process of claim 23, wherein said cross-linking agent is selected from the group consisting of 1,4-butanediol diglycidyl ether, poly-(ethylene glycol) diglycidyl ether, and ethylene glycol diglycidyl ether.

### Claim 26 (depends on 25)

The process of claim 25, wherein said cross-linking agent is poly-(ethylene glycol) diglycidyl ether or ethylene glycol diglycidyl ether.

### Claim 27 (depends on 23)

The process of claim 23, wherein a concentration of said hyaluronic acid in said aqueous medium is between 0.2 and 8 weight percent.

### Claim 28 (depends on 23)

The process of claim 23, wherein a concentration of calcium hydroxyapatite in said aqueous medium is between 0.5 and 5 weight percent.

### Claim 29 (depends on 23)

The process of claim 23, wherein a concentration of calcium hydroxyapatite in said aqueous medium is between 5 and 20 weight percent.

### Claim 30 (depends on 23)

The process of claim 23, wherein said calcium hydroxyapatite has a weight average particle size distribution between 25 and 45 micrometers.

### Claim 31 (depends on 23)

The process of claim 23, wherein said forming comprises extruding said precursor composition through an orifice into a dehydration liquid or onto a drying surface.

### Claim 32 (depends on 23)

The process of claim 23, further comprising sterilizing the dried thread.

### Claim 33

A process of manufacturing a thread of hyaluronic acid and calcium hydroxyapatite comprising:
cross-linking in an aqueous medium hyaluronic acid or a salt thereof by adding a cross-linking agent and increasing the pH of the medium;
neutralizing said aqueous medium;
wherein calcium hydroxyapatite is present in said aqueous medium before said neutralizing, providing a thread precursor composition;
forming said precursor composition into a wet thread; and
drying said wet thread to furnish a dry thread,
wherein the diameter of the thread is essentially uniform, the variation of the diameter expressed as relative standard deviation of diameter of SEM measurements taken along the length of the thread being less than 20%.

### Claim 34 (depends on 33)

The process of claim 33, comprising adding a base to a reaction vessel which was previously charged with hyaluronic acid and a cross-linking agent, to form an alkaline reaction mixture, allowing the reaction mixture to commence cross-linking, adding and dispersing calcium hydroxyapatite into said reaction vessel, allowing said reaction mixture in said reaction vessel to complete cross-linking reaction, and neutralizing said aqueous medium by adding a buffering agent to bring the pH value to an essentially neutral value.

### Claim 35 (depends on 33)

The process of claim 33, wherein said cross-linking agent is selected from the group consisting of 1,4-butanediol diglycidyl ether, poly-(ethylene glycol) diglycidyl ether, and ethylene glycol diglycidyl ether.

### Claim 36 (depends on 35)

The process of claim 35, wherein said cross-linking agent is poly-(ethylene glycol) diglycidyl ether or ethylene glycol diglycidyl ether.

### Claim 37 (depends on 33)

The process of claim 33, wherein a concentration of said hyaluronic acid in said aqueous medium is between 0.2 and 8 weight percent.

### Claim 38 (depends on 33)

The process of claim 33, wherein a concentration of calcium hydroxyapatite in said aqueous medium is between 0.5 and 5 weight percent.

### Claim 39 (depends on 33)

The process of claim 33, wherein a concentration of calcium hydroxyapatite in said aqueous medium is between 5 and 20 weight percent.

### Claim 40 (depends on 33)

The process of claim 33, wherein said calcium hydroxyapatite has a weight average particle size distribution between 25 and 45 micrometers.

### Claim 41 (depends on 33)

The process of claim 33, wherein said forming comprises extruding said precursor composition through an orifice into a dehydration liquid or onto a drying surface.

### Claim 42 (depends on 33)

The process of claim 33, further comprising sterilizing the dried thread.

### Claim 43

A process of manufacturing a thread of hyaluronic acid and calcium hydroxyapatite comprising:
cross-linking in an aqueous medium hyaluronic acid or a salt thereof by adding a crosslinking agent and increasing the pH of the medium;
neutralizing said aqueous medium;
wherein calcium hydroxyapatite is present in said aqueous medium before said neutralizing, providing an extrudable thread precursor composition;
forming said precursor composition into a wet thread; and
drying said wet thread until said wet thread comprises less than 33% of water, to furnish a dry thread.
